Kymera Therapeutics, Inc. (KYMR)
86.26
+3.55
(+4.29%)
USD |
NASDAQ |
May 06, 16:00
84.84
-1.42
(-1.65%)
Pre-Market: 08:26
Kymera Therapeutics Free Cash Flow : -244.00M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Gilead Sciences, Inc. | 9.456B |
| Revolution Medicines, Inc. | -913.73M |
| Catalyst Pharmaceuticals, Inc. | 208.61M |
| Regeneron Pharmaceuticals, Inc. | 3.791B |
| Structure Therapeutics, Inc. | -226.41M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -88.84M |
| Cash from Investing (Quarterly) | -142.84M |
| Cash from Financing (Quarterly) | 18.77M |
| Free Cash Flow Per Share (Quarterly) | -0.9153 |
| Free Cash Flow to Equity (Quarterly) | -87.49M |
| Free Cash Flow to Firm (Quarterly) | -89.21M |
| Free Cash Flow Yield | -3.19% |